Virgo Study Partnerships

Spain:

Infarto de miocardio en la Mujer Joven (IMJOVEN), a study in Spain that is parallel to VIRGO, presents an unprecedented opportunity to learn about the presentation, clinical management, and outcomes for young patients with acute myocardial infarctons (AMI) internationally.

In Spain, more than 55,000 patients are hospitalized with an AMI annually, of whom approximately 2.5% are women younger than 55 years. Despite the lower incidence of AMI among young women (<55 years) in Spain, their mortality rate appears greater than similarly aged men.

IMJOVEN has adopted all VIRGO policies and protocols to ensure complete alignment and data quality across all sites, and will facilitate ancillary studies using data collected both in the United States and Spain. Through this partnership, IMJOVEN hopes to recruit 300 women and 150 men between 18 and 55 years hospitalized with an AMI in Spain.

IMJOVEN is principally funded by Spanish sources (Centro Nacional de Investigación Cardiovascular (CNIC), Fondo de Investigaciones Sanitarias del instituto Carlos III, and Sociedad Española de Cardiología), and is supported by CNIC, the Working Group on Ischemic Heart Disease & Coronary Care Units of the Spanish Society of Cardiology, and the Instituto Carlos III-related national cardiovascular research networks RECAVA (Red de Investigación Cardiovascular), and HERACLES (Hipertensión Esencial: Red de Análisis de Canales iónicos de la musculatura Lisa arterial y su Explotación terapéutica Sistemática). CNIC is led by Valentin Fuster, MD and has tasked Anagram-ESIC, a clinical research organization, with administering the study in Spain.

For more information regarding IMJOVEN, please contact:

Héctor Bueno, MD PhD
Servicio de Cardiología
Hospital General Universitario Gregorio Marañón,
Doctor Esquerdo 46, 28007, Madrid, Spain
Anagram-ESIC